1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Drug Discovery and Development

Drug Discovery & Development Sector: Latest Market Trends and Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Global Drug Discovery and Development Industry

The global drug discovery and development industry (part of the wider pharmaceutical industry) involves the discovery and design of drugs through laboratory testing to treat disease and infection. With costs running high and few drugs making it to the market, drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.

One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process. The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015, according to Business Insights. Meanwhile, the global drug discovery technologies market is expected to be worth more than $32 billion by 2012, growing at an annual compound rate in excess of 8%.

The industry requires heavy investment with no guarantee of results, including under 1% of discoveries going on to be approved by the US Food and Drug Administration. The process itself can take between 12 and 20 years, and cost over the $1.2 billion mark, reports the Alfred Mann Foundation for Biomedical Engineering.

Leading Market Segments

It is estimated that high throughput screening will be worth $12 billion by 2012, showing over 7% growth in the preceding five years.

Bioanalytical instruments have a forecast worth of $10.5 billion in 2012, demonstrating growth in excess of 9%. It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012. Business Insights estimates the electronic data capture market for clinical trials will pass the $1 billion mark in 2016 at 13% annual growth.

Process: Drug Testing and Development

The steps involved in drug discovery begin with the identification of targets, which are genetic or cellular chemicals that influence disease. Once the target has been isolated, the compounds that may work best on them can in turn be determined. Next, the chosen target’s capacity to act on diseased cells is observed before compounds necessary to create a drug are determined, along with the drug target’s response to the compound. In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.

Once a drug has been designed, it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells. The drug also undergoes toxicology testing to determine any possible harm to humans. In the clinical phase, drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug. Research compiled throughout the process is submitted to the relevant authority as the company awaits approval; this part of the process can last up to two years.

Contract Research Organization (CRO) Market Value (2005 - 2010) 

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+44 20 8816 8032

1-10 of about 500 reports

Global Drug Discovery And Development Industry

  • January 2016
    12 pages
  • Drug Discovery ...  

    Drug Developmen...  

  • World  

View report >

Drug Development Industry in the US

  • August 2015
    6 pages
  • Drug Developmen...  

  • United States  

View report >

Drug Discovery And Development Industry in Japan

  • March 2016
    18 pages
  • Drug Discovery ...  

  • Japan  

    Asia  

    World  

View report >

Drug Discovery Industry in Canada

  • January 2015
    98 pages
  • Drug Discovery  

    Therapy  

  • Canada  

View report >

Drug Discovery And Development Industry in Brazil

  • August 2015
    13 pages
  • Drug Discovery ...  

  • Brazil  

    United States  

View report >

Drug Discovery And Development Industry in India - Forecast

  • July 2016
    5 pages
  • Drug Discovery ...  

    Clinical Trial  

  • India  

    Asia  

View report >

Drug Discovery And Development Markets in Australia

  • March 2016
    5 pages
  • Australia  

    Oceania  

View report >

Therapy Market in the US

  • July 2016
    22 pages
  • Therapy  

    Clinical Trial  

  • United States  

    World  

View report >

Search in Drug Discovery And Development Industry (About 500 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Generic Drug, OTC, Pharmacies and Drug Stores, Prescription Drug, Therapy

About 2 400 reports

Purchase Reports From Reputable Market Research Publishers
(From € 200 - € 34 023)

Myocardial Fibrosis - Pipeline Review, H1 2016

Myocardial Fibrosis - Pipeline Review, H1 2016

  • € 34 023
  • Company report
  • June 2016
  • by Global Markets Direct

Myocardial Fibrosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Myocardial Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Myocardial Fibrosis pipeline landscape. ...

Vasomotor Symptoms Of Menopause (hot Flashes) - Pipelin ...

June 2016 € 34 023

Mucopolysaccharidosis I (mps I) (hurler Syndrome ) - Pi ...

June 2016 € 34 023

Liver Failure (hepatic Insufficiency) - Pipeline Review ...

June 2016 € 34 023

Essential Tremor - Pipeline Review, H1 2016

May 2016 € 34 017

Huntington Disease - Pipeline Review, H1 2016

May 2016 € 34 017

Biochips Market By Type Lab-on-a-chip, Protein Chips, E ...

May 2016 € 4 520

Global Urological Cancer Market To 2022 - Strong Growth ...

June 2016 € 3 996

Global Dermatology Market To 2022 - Innovative Pipeline ...

May 2016 € 3 996

Non-small Cell Lung Cancer Therapeutics In Asia-pacific ...

May 2016 € 3 996

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.